John Paulson has joined the board of Wall Street’s nightmare drugmaker

0 Comments 6 view(s)

Valeant CEO Joseph Papa is working to narrow the company’s focus to its dermatology, gastrointestinal and eye care businesses by selling assets to repay debt.